Luca Posa, Pharm.D.

2010-2014 Pharmacology Università di Bologna, Bologna, Italy 
 2012-2013 CNRS & Université Paris Descartes 
 2014-2015 Pharmacology CHU Ste. Justine, Universite de Montreal, Montréal, Québec, Canada 
 2015- Psychiatry McGill University, Montreal, QC, Canada 
opioid, melatonin, pain, tolerance
"Luca Posa"
Mean distance: 17.56 (cluster 32)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

López-Canul M, Min SH, Posa L, et al. (2019) Melatonin MT and MT Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle. International Journal of Molecular Sciences. 20
De Gregorio D, Enns JP, Nuñez NA, et al. (2018) d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Progress in Brain Research. 242: 69-96
De Gregorio D, McLaughlin RJ, Posa L, et al. (2018) Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. Pain
Posa L, De Gregorio D, Gobbi G, et al. (2017) Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain. Current Medicinal Chemistry
De Gregorio D, Comai S, Posa L, et al. (2016) d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. International Journal of Molecular Sciences. 17
De Gregorio D, Posa L, Ochoa-Sanchez R, et al. (2016) The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors. Pharmacological Research. 113: 81-91
Posa L, Accarie A, Noble F, et al. (2015) Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp)
See more...